Establishment Labs Holdings Inc. 是一家醫療技術公司,製造及銷售用於美容及重建整形外科手術的醫療器械。公司總部位於哥斯達黎加阿拉胡埃拉。
財務指標
營業收入
2026-06-30
$67.54M
2026-03-31
$59.87M
2025-12-31
$64.61M
2025-09-30
$53.78M
營業支出
2026-06-30
$52M
2026-03-31
$48.84M
2025-12-31
$49.46M
2025-09-30
$41.72M
淨利潤
2026-06-30
-$11.74M
2026-03-31
-$13.38M
2025-12-31
-$2.61M
2025-09-30
-$11.14M
淨利潤率
2026-06-30
-17.39%
2026-03-31
-22.34%
2025-12-31
-4.04%
2025-09-30
-20.72%
每股收益
2026-06-30
$-0.39
2026-03-31
$-0.40
2025-12-31
$-0.09
2025-09-30
$-0.38
息稅折舊攤銷前利潤
2026-06-30
-$2.04M
2026-03-31
-$3.31M
2025-12-31
-$1.9M
2025-09-30
-$1.97M
有效稅率
2026-06-30
-0.05%
2026-03-31
-2.19%
2025-12-31
78.05%
2025-09-30
-3.95%
項目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
營業收入
$67.54M
$59.87M
$64.61M
$53.78M
營業支出
$52M
$48.84M
$49.46M
$41.72M
淨利潤
-$11.74M
-$13.38M
-$2.61M
-$11.14M
淨利潤率
-17.39%
-22.34%
-4.04%
-20.72%
每股收益
$-0.39
$-0.40
$-0.09
$-0.38
息稅折舊攤銷前利潤
-$2.04M
-$3.31M
-$1.9M
-$1.97M
有效稅率
-0.05%
-2.19%
78.05%
-3.95%
常見問題
ESTA stock represents shares of Establishment Labs Holdings Inc., a medical technology company. The company designs, develops, manufactures, and markets silicone breast implants and related products for aesthetic and reconstructive surgery. Its flagship product line is the Motiva implant brand, which uses proprietary surface technology. ESTA is listed on the Nasdaq Capital Market under the ticker ESTA. Investors often follow the stock as a way to track the medical aesthetics and women's health device market.
The latest ESTA price is shown at the top of this page, along with the day's change, trading volume, and other real-time or delayed market data. Because stock prices change constantly during and outside market hours, the figure displayed here is the most current reference for ESTA. For historical closing prices, you can review the price chart or performance table on this page, which lets you compare recent movement with earlier periods.
ESTA can be influenced by several company-specific and external factors. These include quarterly revenue and earnings results, regulatory approvals or delays for its implants in various countries, product recalls or safety news, and changes in reimbursement or medical device regulations. Broader forces such as interest rates, healthcare sector sentiment, and exchange-rate movements also matter because Establishment Labs sells internationally. Investor expectations around growth in the breast implant market can shift the stock as well.
Because ESTA operates in the medical device industry and may not report consistent positive earnings, simple P/E analysis may be less informative. Investors often look at enterprise value relative to revenue (EV/Sales), price-to-book, gross margin trends, and cash burn. Comparing these metrics with peers in medical aesthetics or surgical devices provides context. The valuation metrics shown on this page give the most current figures, so use those for any up-to-date assessment rather than relying on static numbers.
ESTA can typically be bought through a brokerage account that offers access to U.S. stock exchanges. Once funded, you can place an order to purchase shares using either a market order or a limit order. Market orders execute at the best available price, while limit orders let you set a maximum price for the purchase. Fractional shares may be available through some brokers. The exact steps depend on your brokerage platform, so check its order instructions before trading.
ESTA faces risks including reliance on regulatory approvals for its implant products in key markets, competition from larger medical device makers, and potential product liability or safety concerns. As a smaller company, it may also have limited financial resources and depend on successful product launches to fund operations. Currency fluctuations, changes in healthcare spending, and the possibility of slower-than-expected adoption of its implants can pressure results. These factors can make the stock volatile.